Literature DB >> 21107946

Plasma-mediated disc decompression for contained cervical disc herniation: results through 5 years.

Alessandro Cesaroni1, Pier Vittorio Nardi.   

Abstract

Conventional treatment for cervical disc herniations often defaults to open cervical discectomy, potentially supplemented by intervertebral fusion. Newer treatment strategies focus on percutaneous, minimally invasive procedures which are capable of resolving herniation pathology while offering decreased morbidity and convalescence time when compared to fusion. In cases where patients complain of radicular and neck pain symptoms related to a contained herniated disc, plasma disc decompression may be used as a minimally invasive treatment option on the cervical intervertebral discs.Three hundred and forty-nine patients who presented with a contained herniated cervical disc or focal protrusion causing pain associated with cervical nerve root compression were treated between January 2003 and May 2007. This case series study was conducted to evaluate clinical results through 1 year postoperatively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21107946     DOI: 10.1007/978-3-211-99370-5_17

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  3 in total

1.  Efficacy of coblation technology in treating cervical discogenic upper back pain.

Authors:  Liangliang He; Yuanzhang Tang; Xiuliang Li; Na Li; Jiaxiang Ni; Liangliang He
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

2.  Clinical Efficacy of Selective Focal Ablation by Navigable Percutaneous Disc Decompression Device in Patients With Cervical Herniated Nucleus Pulposus.

Authors:  Sung Hoon Kim; Sang-Heon Lee; Nack Hwan Kim; Min Hyun Kim; Hyeun Jun Park; Yong Jin Jung; Hyun-Joon Yoo; Won Jun Meng; Victoria Kim
Journal:  Ann Rehabil Med       Date:  2017-02-28

3.  Coblation annuloplasty in cervical discogenic pain without radiculopathy.

Authors:  Liangliang He; Jiaxiang Ni; Baishan Wu; Jianing Yue; Guoqing Cao; Yuna Guo; Liqiang Yang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-10-29       Impact factor: 1.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.